Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Tablets

Approval Number

国药准字H20223642

Company苏州二叶制药有限公司

Registration Date

August 30, 2022

Drug Information

Generic Name

利伐沙班片

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

August 30, 2022

Company Information

Applicant Company

Company Name苏州二叶制药有限公司

Company Address

苏州市相城区黄埭镇东桥安民路2号

Manufacturing Company

Company Name

苏州二叶制药有限公司;复星医药(徐州)有限公司

Company Address

苏州市相城区黄埭镇东桥安民路2号；徐州经济技术开发区新徐大道101号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy